144 related articles for article (PubMed ID: 28588010)
1. Micronuclei Frequency in Tumors Is a Predictive Biomarker for Genetic Instability and Sensitivity to the DNA Repair Inhibitor AsiDNA.
Jdey W; Thierry S; Popova T; Stern MH; Dutreix M
Cancer Res; 2017 Aug; 77(16):4207-4216. PubMed ID: 28588010
[TBL] [Abstract][Full Text] [Related]
2. Effect of DNA repair inhibitor AsiDNA on the incidence of telomere fusion in crisis.
Subecz C; Sun JS; Roger L
Hum Mol Genet; 2021 Apr; 30(3-4):172-181. PubMed ID: 33480989
[TBL] [Abstract][Full Text] [Related]
3. AsiDNA Treatment Induces Cumulative Antitumor Efficacy with a Low Probability of Acquired Resistance.
Jdey W; Kozlak M; Alekseev S; Thierry S; Lascaux P; Girard PM; Bono F; Dutreix M
Neoplasia; 2019 Sep; 21(9):863-871. PubMed ID: 31362243
[TBL] [Abstract][Full Text] [Related]
4. Active DNA end processing in micronuclei of ovarian cancer cells.
Tang Z; Yang J; Wang X; Zeng M; Wang J; Wang A; Zhao M; Guo L; Liu C; Li D; Chen J
BMC Cancer; 2018 Apr; 18(1):426. PubMed ID: 29661159
[TBL] [Abstract][Full Text] [Related]
5. The DNA Repair Inhibitor Dbait Is Specific for Malignant Hematologic Cells in Blood.
Thierry S; Jdey W; Alculumbre S; Soumelis V; Noguiez-Hellin P; Dutreix M
Mol Cancer Ther; 2017 Dec; 16(12):2817-2827. PubMed ID: 28947503
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors.
Herath NI; Berthault N; Thierry S; Jdey W; Lienafa MC; Bono F; Noguiez-Hellin P; Sun JS; Dutreix M
Front Oncol; 2019; 9():1097. PubMed ID: 31781480
[No Abstract] [Full Text] [Related]
7. A preclinical study combining the DNA repair inhibitor Dbait with radiotherapy for the treatment of melanoma.
Biau J; Devun F; Jdey W; Kotula E; Quanz M; Chautard E; Sayarath M; Sun JS; Verrelle P; Dutreix M
Neoplasia; 2014 Oct; 16(10):835-44. PubMed ID: 25379020
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of DNA double-strand break repair in multiple myeloma: implications for genome stability.
Herrero AB; San Miguel J; Gutierrez NC
PLoS One; 2015; 10(3):e0121581. PubMed ID: 25790254
[TBL] [Abstract][Full Text] [Related]
9. YU238259 Is a Novel Inhibitor of Homology-Dependent DNA Repair That Exhibits Synthetic Lethality and Radiosensitization in Repair-Deficient Tumors.
Stachelek GC; Peterson-Roth E; Liu Y; Fernandez RJ; Pike LR; Qian JM; Abriola L; Hoyer D; Hungerford W; Merkel J; Glazer PM
Mol Cancer Res; 2015 Oct; 13(10):1389-97. PubMed ID: 26116172
[TBL] [Abstract][Full Text] [Related]
10. In vitro model for DNA double-strand break repair analysis in breast cancer reveals cell type-specific associations with age and prognosis.
Deniz M; Kaufmann J; Stahl A; Gundelach T; Janni W; Hoffmann I; Keimling M; Hampp S; Ihle M; Wiesmüller L
FASEB J; 2016 Nov; 30(11):3786-3799. PubMed ID: 27494941
[TBL] [Abstract][Full Text] [Related]
11. Detection of Impaired DNA Replication and Repair in Micronuclei as Indicators of Genomic Instability and Chromothripsis.
Terradas M; Martín M; Genescà A
Methods Mol Biol; 2018; 1769():197-208. PubMed ID: 29564826
[TBL] [Abstract][Full Text] [Related]
12. Targeting XRCC1 deficiency in breast cancer for personalized therapy.
Sultana R; Abdel-Fatah T; Abbotts R; Hawkes C; Albarakati N; Seedhouse C; Ball G; Chan S; Rakha EA; Ellis IO; Madhusudan S
Cancer Res; 2013 Mar; 73(5):1621-34. PubMed ID: 23253910
[TBL] [Abstract][Full Text] [Related]
13. Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability.
Richardson C; Stark JM; Ommundsen M; Jasin M
Oncogene; 2004 Jan; 23(2):546-53. PubMed ID: 14724582
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of Response and Resistance to DNA Repair Targeted Therapies.
Stover EH; Konstantinopoulos PA; Matulonis UA; Swisher EM
Clin Cancer Res; 2016 Dec; 22(23):5651-5660. PubMed ID: 27678458
[TBL] [Abstract][Full Text] [Related]
15. Induction and repair of DNA double-strand breaks using constant-field gel electrophoresis and apoptosis as predictive markers for sensitivity of cancer cells to cisplatin.
Saleh EM; El-Awady RA; Anis N; El-Sharkawy N
Biomed Pharmacother; 2012 Oct; 66(7):554-62. PubMed ID: 22939736
[TBL] [Abstract][Full Text] [Related]
16. Lower level of BRCA2 protein in heterozygous mutation carriers is correlated with an increase in DNA double strand breaks and an impaired DSB repair.
Arnold K; Kim MK; Frerk K; Edler L; Savelyeva L; Schmezer P; Wiedemeyer R
Cancer Lett; 2006 Nov; 243(1):90-100. PubMed ID: 16448746
[TBL] [Abstract][Full Text] [Related]
17. Impaired nuclear functions in micronuclei results in genome instability and chromothripsis.
Terradas M; Martín M; Genescà A
Arch Toxicol; 2016 Nov; 90(11):2657-2667. PubMed ID: 27542123
[TBL] [Abstract][Full Text] [Related]
18. A rare polymorphic variant of NBS1 reduces DNA repair activity and elevates chromosomal instability.
Yamamoto Y; Miyamoto M; Tatsuda D; Kubo M; Nakagama H; Nakamura Y; Satoh H; Matsuda K; Watanabe T; Ohta T
Cancer Res; 2014 Jul; 74(14):3707-15. PubMed ID: 24830725
[TBL] [Abstract][Full Text] [Related]
19. Methods to Monitor DNA Repair Defects and Genomic Instability in the Context of a Disrupted Nuclear Lamina.
Gonzalo S; Kreienkamp R
Methods Mol Biol; 2016; 1411():419-37. PubMed ID: 27147057
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.
Cousineau I; Abaji C; Belmaaza A
Cancer Res; 2005 Dec; 65(24):11384-91. PubMed ID: 16357146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
